Xiangyu Medical Co.,Ltd (SHA:688626)

Xiangyu Medical Co.,Ltd Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	750.58	733.63	736.61	483.87	515.8	491.24
Other Revenue	9.9	9.9	8.2	4.66	7.7	4.27
Revenue	760.48	743.53	744.81	488.53	523.5	495.51
Revenue Growth (YoY)	-1.33%	-0.17%	52.46%	-6.68%	5.65%	15.93%
Cost of Revenue	264.44	252.61	243.35	170.08	169.57	162.69
Gross Profit	496.04	490.92	501.46	318.44	353.92	332.82
Selling, General & Admin	288.21	274.02	210.41	175.89	140.42	113.99
Research & Development	160.71	152.02	106.75	92.41	68.61	51.55
Other Operating Expenses	-15.8	-7.41	-9	-3.6	0.55	2.88
Operating Expenses	435.61	421.82	310.31	264.77	211.78	170.12
Operating Income	60.43	69.09	191.15	53.67	142.15	162.7
Interest Expense	-7.64	-3.63	-2.66	-0.19	-	-0.17
Interest & Investment Income	24.53	26.6	38.82	37.59	33.73	11.64
Currency Exchange Gain (Loss)	0.07	0.07	0.02	0.02	-0.02	0.06
Other Non Operating Income (Expenses)	-0.47	1.04	2.39	2.61	2.16	1.1
EBT Excluding Unusual Items	76.92	93.17	229.72	93.7	178.02	175.33
Gain (Loss) on Sale of Investments	-	-	-3.24	-1.06	-	-0.31
Gain (Loss) on Sale of Assets	0.06	0.07	0.01	-	-0.01	0.01
Asset Writedown	-0.09	-0.05	-0.02	-0.25	-	-0.14
Other Unusual Items	13.3	14.04	17.55	40.6	44.72	47.9
Pretax Income	90.2	107.24	244.03	132.99	222.72	222.79
Income Tax Expense	3.7	4.38	15.72	9.7	23.18	26.78
Earnings From Continuing Operations	86.5	102.85	228.31	123.3	199.54	196.01
Minority Interest in Earnings	0.32	0.09	-1.17	2.17	2.36	0.25
Net Income	86.82	102.94	227.14	125.47	201.9	196.26
Net Income to Common	86.82	102.94	227.14	125.47	201.9	196.26
Net Income Growth	-61.99%	-54.68%	81.03%	-37.85%	2.87%	52.17%
Shares Outstanding (Basic)	155	156	158	159	150	120
Shares Outstanding (Diluted)	155	156	158	159	150	120
Shares Change (YoY)	-1.44%	-1.12%	-0.68%	6.20%	24.97%	-0.72%
EPS (Basic)	0.56	0.66	1.44	0.79	1.35	1.64
EPS (Diluted)	0.56	0.66	1.44	0.79	1.35	1.64
EPS Growth	-61.43%	-54.17%	82.28%	-41.48%	-17.68%	53.27%
Free Cash Flow	-216.11	-260.3	-251.35	-16.37	31.97	76.69
Free Cash Flow Per Share	-1.39	-1.67	-1.59	-0.10	0.21	0.64
Dividend Per Share	0.240	0.240	0.530	0.240	0.380	0.370
Dividend Growth	-54.73%	-54.73%	120.90%	-36.84%	2.70%	-
Gross Margin	65.23%	66.03%	67.33%	65.18%	67.61%	67.17%
Operating Margin	7.95%	9.29%	25.66%	10.99%	27.15%	32.84%
Profit Margin	11.42%	13.84%	30.50%	25.68%	38.57%	39.61%
Free Cash Flow Margin	-28.42%	-35.01%	-33.75%	-3.35%	6.11%	15.48%
EBITDA	101.18	105.17	208.57	69.74	153.52	173.48
EBITDA Margin	13.30%	14.14%	28.00%	14.27%	29.33%	35.01%
D&A For EBITDA	40.75	36.08	17.41	16.06	11.37	10.78
EBIT	60.43	69.09	191.15	53.67	142.15	162.7
EBIT Margin	7.95%	9.29%	25.66%	10.99%	27.15%	32.84%
Effective Tax Rate	4.10%	4.09%	6.44%	7.29%	10.41%	12.02%
Revenue as Reported	760.48	743.53	744.81	488.53	523.5	495.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.